Search
The Impact of Expanded Indications for Glucagon-Like Peptide-1 Receptor Agonist-Based Anti-Obesity Medications in State Medicaid Fee-For-Service Pharmacy Programs
Apr 14
1 min read
Authors: Alyssa Guest, PharmD, Stephanie Tran, PharmD, MPH, BCPS, and Bethany Holderread, PharmD

Alyssa Guest, PharmD, Stephanie Tran, PharmD, MPH, BCPS, and Bethany Holderread, PharmD, presented their award-winning poster, "The Impact of Expanded Indications for Glucagon-Like Peptide 1 Receptor Agonist-Based Anti-Obesity Medications in State Medicaid Fee-For-Service Pharmacy Programs," at the AMCP Annual Meeting 2026 in Nashville, TN.
The poster was awarded a silver ribbon.




